International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)
Russia · Delayed Price · Currency is RUB 672.00
-1.50 (-0.22%)
At close: Jul 8, 2022
MOEX:GEMA Ratios and Metrics
Market cap in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,033 | - | 10,033 | 10,033 | 10,033 | 14,915 | |
Market Cap Growth | - | - | 0% | 0% | -32.73% | 44.78% |
Enterprise Value | 10,029 | - | 10,045 | 10,171 | 10,076 | 14,939 |
Last Close Price | 672.00 | - | 672.00 | 672.00 | 672.00 | 950.69 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 65.18 | - | 66.35 | 79.77 | 102.20 | 98.94 |
PS Ratio | 25.90 | - | 28.78 | 35.39 | 39.40 | 56.10 |
PB Ratio | 26.96 | - | 33.02 | 22.76 | 67.45 | 66.00 |
P/TBV Ratio | 33.17 | - | 44.55 | 28.18 | 172.94 | 74.92 |
P/FCF Ratio | 54.24 | - | 42.33 | 47.87 | 43.28 | 62.19 |
P/OCF Ratio | 51.91 | - | 40.52 | 44.84 | 41.61 | 61.00 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 26.14 | - | 28.82 | 35.88 | 39.56 | 56.19 |
EV/EBITDA Ratio | 50.66 | - | 53.72 | 64.52 | 70.75 | 105.17 |
EV/EBIT Ratio | 54.84 | - | 56.39 | 68.10 | 72.70 | 108.33 |
EV/FCF Ratio | 54.22 | - | 42.38 | 48.53 | 43.46 | 62.29 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.22 | 1.31 | 0.90 | 0.59 | 1.76 | 0.24 |
Debt / EBITDA Ratio | 1.16 | 1.32 | 1.41 | 1.62 | 1.80 | 0.39 |
Debt / FCF Ratio | 1.22 | 1.27 | 1.15 | 1.24 | 1.13 | 0.23 |
Net Debt / Equity Ratio | -0.56 | -0.62 | -0.17 | 0.14 | 1.19 | 0.08 |
Net Debt / EBITDA Ratio | -0.55 | -0.65 | -0.28 | 0.41 | 1.24 | 0.13 |
Net Debt / FCF Ratio | -0.56 | -0.60 | -0.22 | 0.31 | 0.76 | 0.08 |
Asset Turnover | - | 0.31 | 0.28 | 0.26 | 0.32 | 0.39 |
Inventory Turnover | - | 8.05 | 8.82 | 9.88 | 10.81 | 15.68 |
Quick Ratio | 1.00 | 1.76 | 1.88 | 1.24 | 0.83 | 3.53 |
Current Ratio | 1.02 | 1.80 | 1.92 | 1.36 | 0.90 | 3.58 |
Return on Equity (ROE) | 62.61% | 63.07% | 40.61% | 42.67% | 52.39% | 59.26% |
Return on Assets (ROA) | - | 9.32% | 8.86% | 8.63% | 10.95% | 12.77% |
Return on Invested Capital (ROIC) | 233.56% | 111.36% | 47.09% | 35.99% | 48.62% | 56.41% |
Return on Capital Employed (ROCE) | 24.00% | 18.70% | 17.00% | 13.60% | 18.90% | 26.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.28% | - | 1.51% | 1.25% | 0.98% | 0.87% |
FCF Yield | 1.84% | - | 2.36% | 2.09% | 2.31% | 1.61% |
Dividend Yield | 1.29% | - | 1.50% | 0.95% | 1.19% | 0.91% |
Payout Ratio | 125.66% | 70.34% | 101.44% | 97.58% | 143.69% | 116.27% |
Buyback Yield / Dilution | -0.04% | -0.00% | 0.02% | - | 0.00% | -0.00% |
Total Shareholder Return | 1.25% | -0.00% | 1.52% | 0.95% | 1.20% | 0.91% |